Close Menu
    Facebook X (Twitter) Instagram
    SciTechDaily
    • Biology
    • Chemistry
    • Earth
    • Health
    • Physics
    • Science
    • Space
    • Technology
    Facebook X (Twitter) Pinterest YouTube RSS
    SciTechDaily
    Home»Health»Common Fungal Compound May Be the Key to Fighting Deadly Flu Infections
    Health

    Common Fungal Compound May Be the Key to Fighting Deadly Flu Infections

    By McGill UniversityFebruary 27, 20251 Comment3 Mins Read
    Facebook Twitter Pinterest Telegram LinkedIn WhatsApp Email Reddit
    Share
    Facebook Twitter LinkedIn Pinterest Telegram Email Reddit
    Purple Glowing Flu Virus
    Beta-glucan, a fungal component, may protect against flu-related lung damage by regulating immune responses, reducing inflammation, and improving survival rates. Researchers suggest it could be a promising therapy for influenza.

    Preclinical trial reveals how beta-glucan, a compound found in all fungi, can ‘reprogram’ immune cells to combat lung inflammation.

    A recent study suggests that a common fungal component may help protect against flu-related lung damage.

    Led by Professor Maziar Divangahi from McGill’s Faculty of Medicine and Health Sciences and the Research Institute of the McGill University Health Centre, the research team found that beta-glucan, when given to mice before influenza exposure, reduced lung damage, improved lung function, and lowered the risk of severe illness and death.

    Beta-Glucan and Immune Defense

    Beta-glucan is found in all fungi, including mushrooms and yeast, as well as grains like oats and barley. The scientists discovered that a unique structure of this component can boost defenses against pathogens.

    While most research focuses on stopping the virus from replicating, this study explored how to regulate the body’s immunity to infection, a concept known as “disease tolerance.” The researchers discovered that beta-glucan significantly enhanced flu survival rates by modulating immune responses and preventing severe lung inflammation, a common cause of fatality.

    These results, published in Nature Immunology, highlight beta-glucan as a promising therapy for influenza and other emerging viral pathogens, said the scientists, adding future research will explore whether the findings can be applied to humans.

    “It is remarkable how beta-glucan can reprogram certain immune cells, such as neutrophils, to control excessive inflammation in the lung,” said first author Nargis Khan, who conducted this research as a postdoctoral fellow at McGill and is now an Assistant Professor at the University of Calgary.

    “Neutrophils are traditionally known for causing inflammation, but beta-glucan has the ability to shift their role to reduce it,” added co-first author Kim Tran, who recently completed her Ph.D. at McGill.

    Rebalancing the immune system

    Most flu-related deaths aren’t caused by the virus itself, but by an overreaction of the immune system, said the researchers. This suggests the true danger lies in the host’s own immune response. However, how the immune system becomes so imbalanced remains poorly understood.

    “Beta-glucan is found in the cell walls of all fungi, including some that live in and on our bodies as part of the human microbiome,” explained Divangahi. “It is tempting to hypothesize that the levels and composition of fungi in an individual could influence how their immune system responds to infections, in part because of beta-glucan.”

    With flu season underway and the looming threat of bird flu (H5N1), developing effective therapeutic strategies for respiratory diseases is more critical than ever, he added.

    Reference: “Author Correction: β-Glucan reprograms neutrophils to promote disease tolerance against influenza A virus” by Nargis Khan, Kim A. Tran, Raphael Chevre, Veronica Locher, Mathis Richter, Sarah Sun, Mina Sadeghi, Erwan Pernet, Andrea Herrero-Cervera, Alexandre Grant, Ahmed Saif, Jeffrey Downey, Eva Kaufmann, Shabaana Abdul Khader, Philippe Joubert, Luis B. Barreiro, Bryan G. Yipp, Oliver Soehnlein and Maziar Divangahi, 7 February 2025, Nature Immunology.
    DOI: 10.1038/s41590-025-02099-6

    The research was funded by the Canadian Institutes of Health Research.

    Never miss a breakthrough: Join the SciTechDaily newsletter.
    Follow us on Google and Google News.

    Fungus Immunology Influenza McGill University Public Health
    Share. Facebook Twitter Pinterest LinkedIn Email Reddit

    Related Articles

    Why Aging Lungs Turn Mild Infections Into Life-Threatening Illness

    Unlocking Lifetime Flu Protection: Duke’s Innovative Vaccine Strategy

    Unlock the Full Potential of Vaccines: The Surprising Power of Sleep

    Poor Sleep May Weaken Vaccine Response, Increasing Risk of Infection

    Sleep and Vaccination: The Critical Connection You Need to Know About

    Two for One: Repeated Flu Vaccines Provide Kids Better Protection Against Future Flu Pandemics

    Newly Developed Vaccines Protect Against COVID-19 in Macaques Study

    New Study Outlines a Roadmap for Effective Treatment of COVID-19

    New Tool Monitors Real Time Mutations in Flu – Could Help Stop Replication of Viruses

    1 Comment

    1. Jeff T on February 28, 2025 11:17 pm

      This is how we get “Last of Us”, you know that right?

      Reply
    Leave A Reply Cancel Reply

    • Facebook
    • Twitter
    • Pinterest
    • YouTube

    Don't Miss a Discovery

    Subscribe for the Latest in Science & Tech!

    Trending News

    Millions Take These IBS Drugs, But a New Study Finds Serious Risks

    Scientists Unlock Hidden Secrets of 2,300-Year-Old Mummies Using Cutting-Edge CT Scanner

    Bread Might Be Making You Gain Weight Even Without Eating More Calories

    Scientists Discover Massive Magma Reservoir Beneath Tuscany

    Europe’s Most Active Volcano Just Got Stranger – Here’s Why Scientists Are Rethinking It

    Alzheimer’s Symptoms May Start Outside the Brain, Study Finds

    Millions Take This Popular Supplement – Scientists Discover a Concerning Link to Heart Failure

    The Universe Is Expanding Too Fast and Scientists Can’t Explain Why

    Follow SciTechDaily
    • Facebook
    • Twitter
    • YouTube
    • Pinterest
    • Newsletter
    • RSS
    SciTech News
    • Biology News
    • Chemistry News
    • Earth News
    • Health News
    • Physics News
    • Science News
    • Space News
    • Technology News
    Recent Posts
    • Doctors Surprised by the Power of a Simple Drug Against Colon Cancer
    • Why Popular Diabetes Drugs Like Ozempic Don’t Work for Everyone: The “Genetic Glitch”
    • Scientists Create Improved Insulin Cells That Reverse Diabetes in Mice
    • Scientists Stunned After Finding Plant Thought Extinct for 60 Years
    • A Common Diabetes Drug May Hold the Key to Stopping HIV From Coming Back
    Copyright © 1998 - 2026 SciTechDaily. All Rights Reserved.
    • Science News
    • About
    • Contact
    • Editorial Board
    • Privacy Policy
    • Terms of Use

    Type above and press Enter to search. Press Esc to cancel.